Meeder Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
TGI
EC
EAM
Meeder Asset Management's VYGR Position: Q4 2021 in Review
Meeder Asset Management sold out of Voyager Therapeutics (VYGR) in Q4 2021, closing a stake of 157 shares.
Meeder Asset Management first reported a position in VYGR in Q4 2016 and held it in 15 quarters. The position peaked at $204K in Q2 2019. 59 funds tracked by Wall St. Rank hold VYGR as of Q4 2021.
- Meeder Asset Management reported no remaining Voyager Therapeutics position as of Q4 2021 after selling out during the quarter.
- Meeder Asset Management sold 157 Voyager Therapeutics shares in Q4 2021.
- Meeder Asset Management first reported a position in Voyager Therapeutics in Q4 2016 and held it in 15 quarters.
- Meeder Asset Management's Voyager Therapeutics position peaked at $204K in Q2 2019.
- 59 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2021.
Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.